Setbacks in Parkinson’s Drugs Highlight Need for Novel Therapies This month has seen the failure of main assets in the ...

Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...

An intelligent self-adjusting brain pacemaker could improve the quality-of-life for those living with Parkinson’s disease ...

2024 — Researchers have discovered a network of neurons in the brain of mice that help them make right and left turns. In the future, the discovery may be used in treatment for Parkinson's ...

Researchers Develop Analytical Pipeline to Identify Unexploited ... activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD) in certain ...

Supernus Pharmaceuticals saw strong stock performance, has a diverse drug portfolio, and potential for significant future ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Coya’s investigational product candidate pipeline leverages multiple therapeutic ... of action that is now being developed for the treatment of Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, ...

The U.S. Food and Drug Administration (FDA) encouraged scientists and drug developers to use the alpha-synuclein seed amplification assay (aSyn-SAA) biomarker, discovered in 2023, for research and ...

GOTHENBURG, SE / ACCESSWIRE / September 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 18, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...